US · CNMD
CONMED Corporation
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Largo, FL 33773-4908
- Website
- conmed.com
Price · as of 2025-12-31
$36.80
Market cap 1.42B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $75.40 | +104.89% |
| Intrinsic Value(DCF) | $18.32 | -50.22% |
| Graham-Dodd Method(GD) | $2.91 | -92.11% |
| Graham Formula(GF) | $19.87 | -46.01% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $24.75 | $41.87 | $0.00 | $12.11 | $0.26 |
| 2012 | $26.82 | $177.17 | $0.00 | $12.71 | $19.57 |
| 2013 | $40.45 | $47.39 | $0.00 | $10.36 | $8.80 |
| 2014 | $45.36 | $46.42 | $0.00 | $5.72 | $6.18 |
| 2015 | $37.35 | $43.59 | $0.00 | $5.26 | $6.86 |
| 2016 | $36.79 | $41.47 | $0.00 | $0.00 | $7.42 |
| 2017 | $58.86 | $39.04 | $0.00 | $6.17 | $24.51 |
| 2018 | $72.80 | $57.82 | $0.00 | $4.60 | $22.93 |
| 2019 | $89.14 | $70.63 | $0.00 | $0.00 | $19.04 |
| 2020 | $119.49 | $83.13 | $0.00 | $0.00 | $0.00 |
| 2021 | $133.13 | $101.53 | $0.00 | $4.52 | $52.72 |
| 2022 | $87.80 | $89.53 | $0.00 | $0.00 | $0.00 |
| 2023 | $83.22 | $81.21 | $16.58 | $0.00 | $55.29 |
| 2024 | $62.06 | $72.13 | $0.00 | $14.58 | $55.44 |
| 2025 | $45.79 | $75.40 | $0.00 | $2.90 | $19.87 |
AI valuation
Our deep-learning model estimates CONMED Corporation's (CNMD) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $75.40
- Current price
- $36.80
- AI upside
- +104.89%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$18.32
-50.22% upside
Graham-Dodd
$2.91
-92.11% upside
Graham Formula
$19.87
-46.01% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| CNMD | CONMED Corporation | $36.80 | 1.42B | +105% | -50% | -92% | -46% | 30.20 | 1.38 | 1.03 | 12.53 | — | -3.99 | 53.87% | 9.47% | 3.42% | 4.72% | 4.69% | 2.03% | 0.81 | 4.19 | 2.14 | 0.92 | 4.49 | -6455.00% | 518.00% | -195.00% | 10.62% | 0.54 | 8.22% | 1.74% | 52.60% | 7.88% | 17.02 | 14.68 | 1.61 | 1.97 |
| AHCO | AdaptHealth Corp. | $9.15 | 1.24B | +239% | -53% | — | — | -19.73 | 0.86 | 0.40 | 2.75 | — | -1.18 | 17.52% | 5.74% | -2.18% | -4.27% | 7.18% | -1.50% | 0.12 | 1.76 | 1.02 | 0.67 | 0.16 | -18525.00% | -49.00% | -696.00% | 16.84% | 0.84 | 8.45% | 0.00% | 0.00% | 148.90% | 7.43 | 6.31 | 0.43 | 0.97 |
| AZTA | Azenta, Inc. | $26.98 | 1.24B | +62% | -42% | -40% | — | -28.75 | 0.93 | 2.70 | 25.40 | — | 1.74 | 45.52% | -1.90% | -9.39% | -3.19% | -0.31% | -2.68% | 0.06 | — | 2.98 | 2.23 | -3.12 | -6052.00% | 355.00% | 21029.00% | 2.39% | 0.30 | 2.67% | 0.00% | 0.00% | 0.00% | -121.90 | 35.84 | 2.31 | 4.42 |
| ESTA | Establishment Labs Holdin… | $78.70 | 2.29B | -26% | +32% | — | — | -44.15 | 95.73 | 10.68 | -66.58 | — | 181.85 | 69.32% | -18.48% | -24.19% | -133.25% | -49.45% | -14.51% | 0.12 | -1.54 | 3.04 | 1.86 | 2.22 | -4267.00% | 2714.00% | -2314.00% | -2.53% | -0.62 | -82.02% | 0.00% | 0.00% | 9.21% | -55.92 | -38.31 | 10.34 | 4.85 |
| INMD | InMode Ltd. | $13.75 | 871.18M | +312% | -24% | +30% | -77% | 9.40 | 1.29 | 2.38 | 3.06 | — | 1.29 | 78.54% | 23.05% | 25.33% | 13.53% | 56.67% | 12.09% | 0.02 | — | 9.88 | 8.55 | -2.61 | -3644.00% | -616.00% | -3615.00% | 9.56% | 1.21 | 65.78% | 0.00% | 0.00% | 30.54% | 3.98 | 4.03 | 0.92 | 9.96 |
| KMTS | KESTRA MEDICAL TECHNOLOGI… | $23.28 | 1.36B | +67% | +283% | — | — | -6.49 | 3.60 | 12.35 | -5.57 | -4.28 | 3.60 | 40.47% | -177.85% | -190.28% | 5732.26% | 132.69% | -66.62% | 0.22 | -13.75 | 6.72 | 6.47 | 1.97 | 15147.00% | 11505.00% | 1941.00% | -13.70% | -2.04 | 126.23% | 0.22% | -1.50% | 31.39% | -5.13 | -5.39 | 9.12 | 2.34 |
| NEOG | Neogen Corporation | $11.23 | 2.44B | +204% | -82% | — | — | -1.01 | 0.53 | 1.23 | -2.01 | -0.01 | -2.73 | 47.10% | 1.05% | -122.06% | -41.88% | 0.27% | -27.33% | 0.44 | 0.13 | 3.32 | 1.62 | -0.84 | 1146322.00% | -320.00% | -3914.00% | -4.21% | 0.33 | -1.38% | 0.00% | 0.00% | 0.00% | 200.15 | -40.68 | 2.11 | 0.67 |
| NTLA | Intellia Therapeutics, In… | $13.78 | 1.6B | +45% | -49% | — | — | -3.22 | 2.49 | 24.73 | -3.27 | — | 2.49 | 76.47% | -651.67% | -609.85% | -67.26% | -110.87% | -51.06% | 0.14 | — | 5.08 | 4.42 | 0.15 | -2743.00% | 1692.00% | 0.00% | -21.19% | -3.36 | -89.17% | 0.00% | 0.00% | 4.97% | -2.99 | -3.71 | 19.46 | 0.53 |
| NVCR | NovoCure Limited | $13.67 | 1.53B | +107% | -55% | — | — | -11.06 | 4.43 | 2.30 | -11.25 | — | 4.43 | 74.54% | -23.47% | -20.79% | -38.89% | -119.85% | -13.32% | 0.85 | — | 2.90 | 2.57 | -1.57 | -2179.00% | 828.00% | 932.00% | -5.02% | -0.22 | -58.98% | 0.00% | 0.00% | 22.09% | -8.71 | -17.70 | 2.04 | 0.52 |
| SSII | SS Innovations Internatio… | $4.76 | 921.64M | +1,445% | +6,162% | — | — | -85.61 | 121.83 | 79.40 | -93.41 | — | 121.83 | 40.93% | -91.90% | -92.74% | -138.00% | -81.31% | -56.44% | 1.35 | -19.50 | 1.29 | 0.36 | -1.00 | -3750.00% | 25120.00% | -3573.00% | -0.62% | -0.45 | -43.55% | 0.00% | 0.00% | 0.00% | -87.33 | -163.04 | 80.26 | 31.74 |
| UFPT | UFP Technologies, Inc. | $210.58 | 1.62B | -43% | +6% | -65% | +13% | 23.04 | 3.71 | 2.61 | 14.60 | 146.78 | 18.38 | 28.27% | 15.32% | 11.33% | 17.82% | 14.23% | 10.64% | 0.32 | 9.42 | 1.19 | 0.65 | 0.99 | 1570.00% | 1950.00% | 3871.00% | 5.02% | 0.58 | 14.70% | 0.00% | 0.00% | 4.92% | 18.29 | 21.39 | 2.80 | 5.53 |
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
- CEO
- Patrick J. Beyer
- Employees
- 3.9K
- Beta
- 0.96
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($18.32 ÷ $36.80) − 1 = -50.22% (DCF, example).